Health economists meet the fourth tempter: drug dependency and scientific discourse
- 1 December 2000
- journal article
- research article
- Published by Wiley in Health Economics
- Vol. 9 (8) , 659-667
- https://doi.org/10.1002/1099-1050(200012)9:8<659::aid-hec578>3.0.co;2-0
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Pharmacoeconomic AnalysesPublished by American Medical Association (AMA) ,2000
- Conflict of interest and cost-effectiveness analysis.JAMA, 1999
- Paying the Piper for Pharmacoeconomic StudiesMedical Decision Making, 1998
- A Reappraisal of Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1998
- Making economic evaluations respectableSocial Science & Medicine, 1997
- Manufacturing Consensus, Marketing Truth: Guidelines for Economic EvaluationAnnals of Internal Medicine, 1995
- Why is the Pharmaceutical Industry Investing Increasing Amounts in Health Economic Evaluations?International Journal of Technology Assessment in Health Care, 1995
- Something rotten in the state of clinical and economic evaluations?Health Economics, 1994
- Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1992
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991